Medical Condition News

RSS

Incyte’s ruxolitinib COMFORT-II Phase III trial in MF meets primary endpoint

COMFORT-II, the second pivotal Phase III trial of Incyte Corporation's investigational Janus kinase inhibitor, ruxolitinib, has met its primary endpoint of significantly reducing spleen size in patients with myelofibrosis, when compared to best available therapy.

15 Mar 2011

Chelsea uses PHT's LogPad, SitePad Tablet for clinical study to treat Parkinson's patients with NOH

PHT Corporation announced that Chelsea Therapeutics is using PHT's LogPad System and SitePad Tablet for its ongoing clinical study in Parkinson's disease patients with symptomatic neurogenic orthostatic hypotension.

15 Mar 2011

Researchers discover new key component in lung cancer spread

Researchers discovered a new, key component in the spread of lung cancer as well as a likely way to block it with drugs now in clinical trial. The study was published today (Monday, March 14) in the Journal of Clinical Investigation.

15 Mar 2011

OncoSec signs agreement with Inovio to purchase non-DNA cancer vaccine technology

OncoSec Medical Inc., a developer of innovative and proprietary medical approaches to treat solid tumor cancers with unmet medical needs, announced today that it has signed an agreement with Inovio Pharmaceuticals, Inc. providing for the purchase by OncoSec of certain non-DNA vaccine technology and intellectual property relating to electroporation technology useful for electrochemical and cytokine based immune therapies for treating solid tumors.

15 Mar 2011

Type 2 diabetes drug less likely to cause weight gain, raise cholesterol levels

An inexpensive type 2 diabetes drug that has been around for more than 15 years works just as well and has fewer side effects than a half-dozen other, mostly newer and more expensive classes of medication used to control the chronic disease, new Johns Hopkins research suggests.

15 Mar 2011

Animal study suggests antioxidants during pregnancy may prevent obesity in offspring

New biological research may be relevant to the effects of a mother's high-fat diet during pregnancy on the development of obesity in her children.

15 Mar 2011

New tool can measure brain waves in children with cerebral palsy

A new tool which measures brain waves in children with physical and neurological impairments such as cerebral palsy, is being developed by researchers at the University of Hertfordshire and is featured on You Tube today.

15 Mar 2011

Specific inflammatory factor may be responsible for aortic stenosis development

Research from Karolinska Institutet in Sweden shows that a specific inflammatory factor may be important in the development of the heart valve disease aortic stenosis. The results suggest that anti-inflammatory medication could be a possible new treatment.

15 Mar 2011

Innovative orthopedic operation using 'telescoping rods' performed at HSS

An innovative operation using "telescoping rods" performed at Hospital for Special Surgery in Manhattan enabled a young Long Island boy to walk for the first time, and the child and his mother are going to Washington, D.C., to tell their story.

15 Mar 2011

Scientists identify unique function of Twist1 in tumor metastasis

In the early stages of human embryogenesis, a transcription factor called Twist1 plays a key regulatory role in how the embryo assumes form and function. Much later in life, however, researchers at the University of California, San Diego School of Medicine, say Twist1 can re-emerge, taking a darker and more deadly turn.

15 Mar 2011

Cellpraxis, USF Health, UNIFESP present and evaluate ReACT results at scientific meeting

Cellpraxis, USF Health and UNIFESP presented and evaluated the clinical results of an innovative therapy for Refractory Angina patients in a scientific meeting and workshop in São Paulo, Brazil.

15 Mar 2011

U-M receives NIFA grant to reduce childhood obesity among preschoolers

The USDA's National Institute of Food and Agriculture has awarded $4.9 million to the University of Michigan to reduce the prevalence of childhood obesity among Head Start preschoolers in Michigan.

15 Mar 2011

New findings help explain why toxoplasmosis causes serious disease

Providing clues into why the severity of a common parasitic infection can vary greatly from person to person, a new Johns Hopkins study shows that each one of three strains of the cat-borne parasite Toxoplasma gondii sets off a unique reaction in the nerve cells it invades.

15 Mar 2011

Experts to discuss on Alzheimer's disease prevention and treatment at ADI conference

From drug therapies to the right type of diet, the world's leading dementia experts will focus on the most effective methods for preventing and treating Alzheimer's disease and related dementias at the 26th Annual Conference of Alzheimer's Disease International.

15 Mar 2011

New report finds nearly 15 million Alzheimer's and dementia caregivers in the U.S.

According to 2011 Alzheimer's Disease Facts and Figures, released today by the Alzheimer's Association, there are nearly 15 million Alzheimer's and dementia caregivers in the United States.

15 Mar 2011

Oxford Biomedica’s TroVax(R) TRIST Phase III study results to be published in Cancer Immunology, Immunotherapy

Oxford BioMedica plc, a leading gene therapy company, today announces that further analyses of the TroVax Renal Immunotherapy Survival Trial, a randomised, double-blind, placebo-controlled Phase III study, have been accepted for publication in Cancer Immunology, Immunotherapy, the official journal of the Association for Cancer Immunotherapy.

15 Mar 2011

Researchers develop novel system to show how specific mutations can induce glioblastoma

Mutations in three pathways important for suppressing tumors cooperate to launch glioblastoma, an aggressive brain tumor that strikes children and adults. But new research from St. Jude Children's Research Hospital scientists shows those changes alone are not sufficient to cause cancer.

15 Mar 2011

New insight into neurodegenerative disorders

Research into how the brain transmits messages to other parts of the body could improve understanding of disorders such as epilepsy, dementia, multiple sclerosis and stroke.

15 Mar 2011

National clinical DPTT to help improve diabetes control

The Stony Brook University School of Dental Medicine is leading a multicenter national clinical trial to evaluate whether treatment of chronic periodontitis will help improve diabetes control. Sponsored by the National Institutes of Health, the Diabetes and Periodontal Therapy Trial monitors blood sugar levels of those with Type 2 diabetes after periodontal therapy.

15 Mar 2011

eToims launches new program with leading football franchise to improve athletic therapy

eToims Medical Technology has announced an innovative Sports Development Program with a leading UK football franchise to refine and improve athletic therapy and conditioning.

15 Mar 2011

Medical Condition News

Incyte’s ruxolitinib COMFORT-II Phase III trial in MF meets primary endpoint

Chelsea uses PHT's LogPad, SitePad Tablet for clinical study to treat Parkinson's patients with NOH

Researchers discover new key component in lung cancer spread

OncoSec signs agreement with Inovio to purchase non-DNA cancer vaccine technology

Type 2 diabetes drug less likely to cause weight gain, raise cholesterol levels

Animal study suggests antioxidants during pregnancy may prevent obesity in offspring

New tool can measure brain waves in children with cerebral palsy

Specific inflammatory factor may be responsible for aortic stenosis development

Innovative orthopedic operation using 'telescoping rods' performed at HSS

Scientists identify unique function of Twist1 in tumor metastasis

Cellpraxis, USF Health, UNIFESP present and evaluate ReACT results at scientific meeting

U-M receives NIFA grant to reduce childhood obesity among preschoolers

New findings help explain why toxoplasmosis causes serious disease

Experts to discuss on Alzheimer's disease prevention and treatment at ADI conference

New report finds nearly 15 million Alzheimer's and dementia caregivers in the U.S.

Oxford Biomedica’s TroVax(R) TRIST Phase III study results to be published in Cancer Immunology, Immunotherapy

Researchers develop novel system to show how specific mutations can induce glioblastoma

New insight into neurodegenerative disorders

National clinical DPTT to help improve diabetes control

eToims launches new program with leading football franchise to improve athletic therapy

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Latest News